Sodium-glucose cotransporter 2 inhibitors and risk of hyperkalemia in people with type 2 diabetes: a meta-analysis of individual participant data from randomized controlled trials
Neuen BL, Oshima M, Agarwal R, et al.
Circulation. Pub. online 8 Apr 2022
Leggi


